In pulmonary neoplasia, hyperactivation of inflammatory mediator production by tumour-associated alveolar macrophages yields marked surges in IL-6– and IL-1–related factors both locally and systemically, correlating with adverse clinical trajectories [213,214,215]. Here, IL6 is linked to neoplasm.